Mersana Therapeutics, Inc.: capex
| Value | {"amount": 0, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a93086fa-4d54-41e9-97a3-820a88c51cd4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-025679Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/capex/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a93086fa-4d54-41e9-97a3-820a88c51cd4
History
- no predecessors — first report